Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04115254
What this trial is testing

Stereotactic Magnetic Resonance Guided Radiation Therapy

Who this might be right for
Pancreas CancerLung CancerRenal Cancer+10 more
Dana-Farber Cancer Institute 397
Not applicableUnknownNCT00670527
What this trial is testing

[18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases

Who this might be right for
Prostate Cancer
Odense University Hospital 205
Testing effectiveness (Phase 2)Study completedNCT00817739
What this trial is testing

Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c

Who this might be right for
Prostatic Neoplasms
Takeda 341
Not applicableStudy completedNCT01436877
What this trial is testing

Assessing Safety & Efficacy of MediTate Temporary Implant in Subjects With Benign Prostate Hyperplasia

Who this might be right for
Bladder Neck ObstructionBenign Prostate Hyperplasia
Medi-Tate Ltd. 32
Testing effectiveness (Phase 2)Ended earlyNCT00104130
What this trial is testing

Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 53
Large-scale testing (Phase 3)Study completedNCT00622973
What this trial is testing

USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases

Who this might be right for
Prostate CancerBladder Cancer
Insel Gruppe AG, University Hospital Bern 130
Early research (Phase 1)Study completedNCT02274623
What this trial is testing

Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid

Who this might be right for
Breast CancerProstate CancerBone Neoplasms+2 more
OPKO Health, Inc. 33
Large-scale testing (Phase 3)Active Not RecruitingNCT02194842
What this trial is testing

Phase III Radium 223 mCRPC-PEACE III

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 446
Testing effectiveness (Phase 2)UnknownNCT05268666
What this trial is testing

Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid Tumor
Jubilant Therapeutics Inc. 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT07285694
What this trial is testing

AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Arsenal Biosciences, Inc. 190
Testing effectiveness (Phase 2)Active Not RecruitingNCT05924672
What this trial is testing

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneStage IVB Prostate Cancer AJCC v8
University of California, San Francisco 2
Post-approval studies (Phase 4)UnknownNCT03202381
What this trial is testing

Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix

Who this might be right for
Prostate Cancer
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 35
Testing effectiveness (Phase 2)Study completedNCT00436956
What this trial is testing

AZD2171 to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 59
Not applicableUnknownNCT05161728
What this trial is testing

PSMA Response in Metastasized Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Roderick van den Bergh 150
Post-approval studies (Phase 4)Study completedNCT00334139
What this trial is testing

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

Who this might be right for
Prostate CancerBreast CancerBone Metastasis
Novartis Pharmaceuticals 411
Early research (Phase 1)Study completedNCT02234921
What this trial is testing

Pilot Study of DRibble Vaccine for Prostate Cancer Patients

Who this might be right for
Adenocarcinoma of the Prostate
UbiVac 3
Not applicableLooking for participantsNCT02997709
What this trial is testing

Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients

Who this might be right for
Prostate Cancer
University of Miami 144
Post-approval studies (Phase 4)Study completedNCT00219219
What this trial is testing

Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases

Who this might be right for
Prostate Cancer
Novartis
Testing effectiveness (Phase 2)Looking for participantsNCT06594926
What this trial is testing

Working Out M0 Bipolar Androgen Therapy

Who this might be right for
Prostate Cancer
Australian and New Zealand Urogenital and Prostate Cancer Trials Group 69
Not applicableStudy completedNCT01833208
What this trial is testing

Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T

Who this might be right for
Hormone-Resistant Prostate CancerMetastatic Malignant Neoplasm in the BoneRecurrent Prostate Carcinoma+1 more
Roswell Park Cancer Institute 15
Next Page